Importance of Extranuclear Estrogen Receptor-alpha and Membrane G Protein-coupled Estrogen Receptor in Pancreatic Islet Survival
Overview
Authors
Affiliations
Objective: We showed that 17beta-estradiol (E(2)) favors pancreatic beta-cell survival via the estrogen receptor-alpha (ERalpha) in mice. E(2) activates nuclear estrogen receptors via an estrogen response element (ERE). E(2) also activates nongenomic signals via an extranuclear form of ERalpha and the G protein-coupled estrogen receptor (GPER). We studied the contribution of estrogen receptors to islet survival.
Research Design And Methods: We used mice and islets deficient in estrogen receptor-alpha (alphaERKO(-/-)), estrogen receptor-beta (betaERKO(-/-)), estrogen receptor-alpha and estrogen receptor-beta (alphabetaERKO(-/-)), and GPER (GPERKO(-/-)); a mouse lacking ERalpha binding to the ERE; and human islets. These mice and islets were studied in combination with receptor-specific pharmacological probes.
Results: We show that ERalpha protection of islet survival is ERE independent and that E(2) favors islet survival through extranuclear and membrane estrogen receptor signaling. We show that ERbeta plays a minor cytoprotective role compared to ERalpha. Accordingly, betaERKO(-/-) mice are mildly predisposed to streptozotocin-induced islet apoptosis. However, combined elimination of ERalpha and ERbeta in mice does not synergize to provoke islet apoptosis. In alphabetaERKO(-/-) mice and their islets, E(2) partially prevents apoptosis suggesting that an alternative pathway compensates for ERalpha/ERbeta deficiency. We find that E(2) protection of islet survival is reproduced by a membrane-impermeant E(2) formulation and a selective GPER agonist. Accordingly, GPERKO(-/-) mice are susceptible to streptozotocin-induced insulin deficiency.
Conclusions: E(2) protects beta-cell survival through ERalpha and ERbeta via ERE-independent, extra-nuclear mechanisms, as well as GPER-dependent mechanisms. The present study adds a novel dimension to estrogen biology in beta-cells and identifies GPER as a target to protect islet survival.
Du J, Liu J, Wang X, Wang X, Ma Y, Zhang S Biol Direct. 2025; 20(1):28.
PMID: 40065410 PMC: 11895175. DOI: 10.1186/s13062-025-00618-x.
miR-10a/b-5p-NCOR2 Regulates Insulin-Resistant Diabetes in Female Mice.
Ha S, Singh R, Jin B, Baek G, Jorgensen B, Zogg H Int J Mol Sci. 2024; 25(18).
PMID: 39337631 PMC: 11432729. DOI: 10.3390/ijms251810147.
Neuroactive steroids in the neuroendocrine control of food intake, metabolism, and reproduction.
Rasic-Markovic A, Djuric E, Skrijelj D, Bjekic-Macut J, Ignjatovic D, Sutulovic N Endocrine. 2024; 85(3):1050-1057.
PMID: 38635064 DOI: 10.1007/s12020-024-03755-x.
Jacobo-Piqueras N, Theiner T, Geisler S, Tuluc P JCI Insight. 2024; 9(6).
PMID: 38358819 PMC: 11063940. DOI: 10.1172/jci.insight.171609.
Follicle-stimulating hormone orchestrates glucose-stimulated insulin secretion of pancreatic islets.
Cheng Y, Zhu H, Ren J, Wu H, Yu J, Jin L Nat Commun. 2023; 14(1):6991.
PMID: 37914684 PMC: 10620214. DOI: 10.1038/s41467-023-42801-6.